Traders Buy Anthropic at $1.8T Valuation on Pre-IPO Perps, Calling It a No-Brainer
adamamcbride · x · 2026-11-18
X users discuss buying Anthropic exposure at a $1.8T valuation on pre-IPO perpetuals, arguing it's a pure 'AI intelligence' play backed by deep government ties—even while admitting it's probably a bad business. One jokes about logging into Etrade to cancel an IPO order instead. The thread captures the speculative premium around Anthropic in the pre-IPO perps market.
More from Venture
- Perplexity CEO Reveals $1B ARR With Strong Margins and Healthy Growth — inductionheads · 2026-11-18
- SEO consultant pitches 14 journalists a week, calls GEO "BS" — gaganghotra_ · 2026-11-18
- Boltz's long-term goal: hypothesis to human-ready molecule without leaving the computer — GabriCorso · 2026-11-18
- Boltz Lab now a daily tool for pharma scientists; partners include Pfizer, GSK, Takeda, BMS — GabriCorso · 2026-11-18
- Boltz raises $110M Series A for AI biomolecular design, partners with 6 top-20 pharma giants — GabriCorso · 2026-11-18
- Anthropic IPO: $70-78/share, up to ~$1.4T valuation, ~$90B raise with supplier private placement — RihardJarc · 2026-11-18